Summary
The potential of small unilamellar liposomes coupled to anti-tumour monoclonal antibodies (immunoliposomes) to accumulate in solid tumour tissue was tested in two systems, i.e. a human malignant melanoma xenografted into nude mice and a syngeneic murine lymphoma ESb.Mp exhibiting spontaneous metastasis to the liver. Both monoclonal antibodies tested were partly released from immunoliposomes within a few hours, thus generating a seemingly constant level of circulating antibody. Nevertheless it was possible to follow the biodistribution of intact immunoliposomes by virtue of a radioiodine label incorporated into the lipid moiety. It was found that in both tumor systems, though they differed with respect to the size of lesions and maybe also to the vascular architecture of surrounding tissue, immunoliposome uptake was virtually nil. The blockade of uptake into solid tumour tissue was caused by the limited availability of immunoliposomes due to their moderate stability, but especially by the inability of the particulate carrier to extravasate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abra RM, Schreier H, Szoka FC (1982) The use of a new radioactive-iodine labelled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsuled aqueous space marker. Res Commun Chem Pathol Pharmacol 37: 199
Altevogt P, Kohl U, Von Hoegen P, Lang E, Schirrmacher V (1989) Antibody 12–15 cross-reacts with mouse Fc(gamma) receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein. Eur J Immunol 19: 341
Benke R, Lang E, Komitowski D, Muto S, Schirrmacher V (1988) Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth. Invasion Metastasis 8: 159
Blackey DC, Watson GJ, Knowles PP, Thorpe PE (1987) Effect of chemical deglycosylation of ricin A-chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A-chain and anti-Thy 1.1 antibody. Cancer Res 47: 947
Connor J, Sullivan S, Huang L (1985) Monoclonal antibody and liposomes. Pharmacol Ther 28: 341
Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 85: 6949
Hashimoto Y, Sugawara M, Masuko T, Hojo H (1983) Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Cancer Res 43: 5328
Hwang KJ, Padki MM, Chow DD, Essien HE, Lai JY, Beaumier PL (1987) Uptake of small liposomes by non-reticuloendothelial tissues. Biochim Biophys Acta 901: 88
Kibat P, Stricker H (1988) Drug Res 38: 1472
Konno H, Suzuki H, Tadakuma T, Kumai K, Yasuda T, Kubota T, Ohta S, Nagaike K, Hosokawa S, Ishibiki K, Abe O, Saito K (1987) Antitumor effect of Adriamycin entrapped in liposomes conjugated with anti-human α-fetoprotein monoclonal antibody. Cancer Res 47: 4471
Leserman LD, Machy P, Devaux C, Barbet J (1989) Antibody-bearing liposomes: targeting in vivo. Biol Cell 47: 111
Matzku S, Kirchgessner H, Nissen M (1987) Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: Immunoreactivity changes related to the site of iodine incorporation. Nucl Med Biol 14: 451
Matzku S, Kirchgessner H, Schirrmacher V (1988) Antibody targeting to the murine lymphoma ESb-MP: increased accumulation due to reduced internalization into lymphoma cells as compared to normal lymphoid cells. Int J Cancer 41: 108
Onuma M, Odawara T, Watarai S, Aida Y, Ochiai K, Syuto B, Matsumoto K, Yasuda T, Fujimoto Y, Izawa H, Kawakami Y (1986) Antitumor effect of Adriamycin entrapped in liposomes conjugated with monoclonal antibodies against tumor-associated antigen of bovine leukemia cells. Jpn J Cancer Res 77: 1161
Papahadjopoulos D, Gabizon A (1987) Targeting of liposomes to tumor cells in vivo. In: Juliano RL (ed) Biological approaches to the controlled delivery of drugs. Ann NY Acad Sci 507: 64
Pflüger E, Lang E, Benke R, Heckl-Östreicher B, Altevogt P, Schirrmacher V (1988) Generation of adhesive tumor variants: chromosomal changes, reduction in malignancy and increased expression of a distinct membrane glycoprotein. Clin Exp Metastasis 6: 485
Poste G, Kirsh R (1989) Site-specific (targeted) drug delivery in cancer therapy. Biotechnology 869
Proffitt RT, Williams LE, Presant CA, Tin GW, Uliana JA, Gamble RC, Baldeschwieler JD (1983) Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J Nucl Med 24: 45
Schroit AJ, Madsen J, Nayar R (1986) Liposome-cell interactions: In vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. Chem Phys Lipids 40: 373
Storm G, Roerdink FH, Steerenberg PA, de Jong WH, Crommelin DJA (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res 47: 3366
Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C (1983) Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. Cancer Immunol Immunother 16: 53
Tadakuma T (1986) Targeting therapy of human solid tumor cells with liposomes bearing monoclonal antibodies: In: Yagi K (ed) Medical application of liposomes. Japan Scientific Societies Press, Tokyo, p 113
Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown A NF, Watson GJ, Knyba RE, Wawrzynczak WJ, Blakey DC (1987) New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res 47: 5924
Warren BA (1979) The vascular morphology of tumors. In: Peterson H-I (ed) Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. CRC Press, Boca Raton, Fla, p 1
Weckenmann HP, Stricker H, Matzku S (1988) Optimization of the covalent binding of monoclonal antibodies to liposomes. Drug Res 38: 1556
Weckenmann HP, Matzku S, Stricker H, Sinn H (1989) Stability in biological fluids and clearance of immunoliposomes. Drug Res 39: 415
Yatvin MB (1982) Clinical prospects for liposomes. Med Phys 9: 149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matzku, S., Krempel, H., Weckenmann, HP. et al. Tumour targeting with antibody-coupled liposomes: Failure to achieve accumulation in xenografts and spontaneous liver metastases. Cancer Immunol Immunother 31, 285–291 (1990). https://doi.org/10.1007/BF01740936
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01740936